読み込み中
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
最新データ
￥717
−￥20.00 · -2.71%
日中の時刻はJSTです。市場データは遅延する場合があります。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日中レンジ
現在 ￥717
52週レンジ
現在 ￥717
日中の時刻はJSTです。市場データは遅延する場合があります。
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
日中レンジ
現在 ￥717
52週レンジ
現在 ￥717
営業利益
純利益
| 指標（JPY） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | — | — | 10億 JPY | — | — |
| 売上原価 | — | — | 9000万 JPY | — | 680.3万 JPY |
| 粗利益 | — | — | 9.1億 JPY | — | −680.3万 JPY |
| 研究開発 | — | 4.52億 JPY | — | 1.64億 JPY | 1.35億 JPY |
| 販売・一般管理 | 9.16億 JPY | 3.79億 JPY | −1000 JPY | 1.69億 JPY | 6797.1万 JPY |
| 営業費用 | 9.16億 JPY | 8.36億 JPY | 5.44億 JPY | 3.54億 JPY | 2.13億 JPY |
| 受取利息 | 300.3万 JPY | 26.5万 JPY | 1.6万 JPY | 7000 JPY | 1000 JPY |
| 支払利息 | 731.1万 JPY | — | 1184.9万 JPY | — | — |
| 減価償却費と償却費 | — | — | 1000 JPY | — | 680.3万 JPY |
| 営業利益 | −9.16億 JPY | −8.36億 JPY | 3.66億 JPY | −3.54億 JPY | −2.19億 JPY |
| 純利益 | −9.93億 JPY | −8.46億 JPY | 2.6億 JPY | −3.92億 JPY | −2.29億 JPY |
会社概要が更新されました 2026年10月15日.
直近の発表実績
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
